Ross Cheloha
@rche54.bsky.social
590 followers 680 following 60 posts
Investigator studying Chemical Biology of Signalling. Science, junk food, and Nebraska athletics enthusiast. Posts-my own and not my employer's https://scholar.google.com/citations?user=QlaNnS0AAAAJ&hl=en
Posts Media Videos Starter Packs
rche54.bsky.social
Read this in a paper and it was totally new to me (after 18 years in biochemistry research): “Peptides translated from the sense and antisense strands of DNA interact specifically, analogous to the complementary interactions between DNA double strands.” Is this widely studied/actually true?? 🤯
Reposted by Ross Cheloha
fannychasseloup.bsky.social
Last day at #ENDO2025 was great! Amazing symposium on bone and calcium disorders 🦴 by @rche54.bsky.social @MichailLionakis @MichaelMannstadt with great talks on GPCRs and nanobodies, JAK inhibitors in APECED syndrome & new PTH therapies 🤩
Reposted by Ross Cheloha
jameswchecco.bsky.social
This Wednesday and Thursday is the VIRTUAL Nebraska Drug Discovery and Development Pipeline Symposium! Registration is still open! Plenary speakers include Brian Kobilka and Virginia Man-Yee Lee.

#chemsky, you should attend!

research.unl.edu/blog/annual-...
Annual Nebraska Drug Discovery and Development Pipeline symposium June 25-26
World-renowned experts will offer their insights during the fifth annual ND3P Symposium, set for June 25-26. The symposium will be virtual and highly interactive.
research.unl.edu
rche54.bsky.social
Check out the final published product in Journal of Biological Chemistry! www.jbc.org/article/S002...
Reposted by Ross Cheloha
Reposted by Ross Cheloha
freddyeescorcia.bsky.social
Next up, a collaboration with Ross Cheloha's group (@rche54 <a href="https://bsky.app/profile/did:plc:ycxfqyv32syaeu347y4xquiw" class="hover:underline text-blue-600 dark:text-sky-400" target="_blank" rel="noopener">@rche54.bsky.social) and @MitchellHo leveraging a novel self-labeling approach for site-specific modification of nanobodies for biological applications.

doi.org/10.1002/advs...
3/5
Reposted by Ross Cheloha
freddyeescorcia.bsky.social
It's been a while since I posted on some of the ☢️ #radiopharmaceuticals ☢️ work we've been brewing.

Let's fix that...

🧵👇
1/5
Reposted by Ross Cheloha
doc-jlmeier.bsky.social
Great news: NIH postbac program is recruiting again! If your grad school plans were affected by program cutbacks or admissions freezes this year I highly encourage you to apply, this could be a perfect opportunity. Please repost.

www.training.nih.gov/research-tra...
www.training.nih.gov
Reposted by Ross Cheloha
alphafold.bsky.social
The findings suggest that optimizing input parameters and refining competition-based modeling approaches may enhance predictive accuracy for antibody-antigen interactions. Intriguing.
rche54.bsky.social
Finally we compared models of nanobody-epitope to nanobody-antigen complexes. In one case Alphafold produced an accurate model with epitope but failed with antigen! This highlights the potential utility of simplifying Alphafold inputs for generating models with improved accuracies (4/4)
rche54.bsky.social
We further showed that Alphafold could be used in a competition mode to identify peptides that bound nanobody with higher affinity than the wild type epitope peptide. We also used modeling to guide design of a peptide-electrophile conjugate that forms a crosslink with nanobody (3/n)
rche54.bsky.social
We performed modeling of experimentally characterized nanobody-peptide interactions and found that 4/6 models matched experimental data. We also crystallized a new nanobody-peptide complex and showed good concordance between the x-ray structure (my first listing on the pdb!) (2/n)
rche54.bsky.social
We’re excited to apply this for cell-type specific targeting of gpcrs! Congrats to postdocs Shivani Sachdev and Swarnali Roy on the great work (3/3)
rche54.bsky.social
We also show that the activity of these conjugates is dependent on nanobody binding. This property allows us to make conjugates that act in an “and” logic gated manner-only active if 2 different targets are coexpressed on on a single cell. (2/n)
rche54.bsky.social
Proud to share this work from my group in the intramural research program at NIH! We describe a new kind of conjugate made from a small molecule adenosine analog linked to a GPCR targeting nanobody to make antibody drug conjugates that potently and specifically activate signaling (1/n) 🧪 #chembio
biorxivpreprint.bsky.social
Nanobody-based conjugates targeting small molecule-binding GPCRs and exhibiting logic-gated signaling https://www.biorxiv.org/content/10.1101/2025.03.07.642093v1
Reposted by Ross Cheloha
biorxivpreprint.bsky.social
Nanobody-based conjugates targeting small molecule-binding GPCRs and exhibiting logic-gated signaling https://www.biorxiv.org/content/10.1101/2025.03.07.642093v1
rche54.bsky.social
One good thing I saw today
Big gulp 1 gallon drink bag. Big ole plastic bag with a red lid
rche54.bsky.social
This work was made possible through contributions from experts in multiple fields (chemistry, cancer imaging, antibody discovery) working together! The methods described may be useful for the development of imaging probes to provide diagnostic info on other types of tumors or other diseases (3/3)
rche54.bsky.social
The ability to visualize tumors enables an assessment of whether treatments are working or whether cancer has spread. This imaging requires probes that specifically label cancer cells. We developed a new chemistry for creating probes that label liver cancer tumors. (2/n)
rche54.bsky.social
I'm actually related to him (second cousins or so)! Can definitely ID the 90's Huskers fans by their reaction when I share this connection